Bumper Offer - Urjas oil Just @ Rs. 1 X
Valprol CR 500 Tablet (10) is a prescription medicine that is available as a Tablet. Epilepsy are some of its major therapeutic uses. Secondary and off-label uses of Valprol CR 500 Tablet (10) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Valprol CR 500 Tablet (10). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The side effects typically associated with Valprol CR 500 Tablet (10) include Loss of appetite. Some other side effects of Valprol CR 500 Tablet (10) have been listed ahead. These side effects of Valprol CR 500 Tablet (10) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Valprol CR 500 Tablet (10)'s effect is Severe during pregnancy and Mild for lactating mothers. Further, the section on Valprol CR 500 Tablet (10) related warnings talks about Valprol CR 500 Tablet (10)'s effects on the liver, heart and kidney.
Valprol CR 500 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Valprol CR 500 Tablet (10) in conditions like Depression, Liver Disease. Some other conditions that can be affected by Valprol CR 500 Tablet (10) are listed in the contraindications section below.
Additionally, Valprol CR 500 Tablet (10) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Valprol CR 500 Tablet (10) is not safe while driving, and is not addiction.
Valprol CR 500 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Valprol CR 500 Tablet (10) safe for pregnant women?
Valprol CR should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Valprol CR 500 Tablet (10) safe during breastfeeding?
Side effects of Valprol CR on breastfeeding women are very mild.
What is the effect of Valprol CR 500 Tablet (10) on the Kidneys?
Valprol CR rarely harms the kidneys.
What is the effect of Valprol CR 500 Tablet (10) on the Liver?
Very few cases of side effects of Valprol CR on the liver have been reported.
What is the effect of Valprol CR 500 Tablet (10) on the Heart?
Valprol CR is not harmful for the heart.
Valprol CR 500 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Valprol CR 500 Tablet (10) unless your doctor advises you to do so -
Is this Valprol CR 500 Tablet (10) habit forming or addictive?
Valprol CR 500 Tablet (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Valprol CR 500 Tablet (10), you should not drive or work on any heavy machine, as Valprol CR 500 Tablet (10) can make you drowsy.
Is it safe?
Yes, Valprol CR 500 Tablet (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Valprol CR 500 Tablet (10) can treat mental disorders.
Interaction between Food and Valprol CR 500 Tablet (10)
Taking Valprol CR 500 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Valprol CR 500 Tablet (10)
Consult your doctor before consuming alcohol while taking Valprol CR 500 Tablet (10) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)